BIOMAT Database Logo BIOMAT Database Logo

Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study. 2011

Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Hospital Local del Norte, Bucaramanga, Colombia. rortiz@unab.edu.co

OBJECTIVE To evaluate the efficacy and safety of iron(III) polymaltose complex (Maltofer(®)) versus ferrous sulfate in iron-deficient pregnant women using recommended doses. METHODS An exploratory, open-label, randomized, controlled, multicenter study was undertaken in 80 pregnant women with iron-deficiency anemia (hemoglobin ≤ 10.5 g/dL, serum ferritin ≤ 15 ng/mL and mean corpuscular volume < 80 fL). Patients were randomized 1:1 to oral iron(III) polymaltose complex or ferrous sulfate (each 100 mg iron twice daily) for 90 days. RESULTS The primary endpoint, change in hemoglobin from baseline to days 60 and 90, did not differ significantly between treatment groups. The mean (SD) change to day 90 was 2.16 (0.67) g/dL in the iron(III) polymaltose complex group and 1.93 (0.97) g/dL in the ferrous sulfate group (n.s). Mean serum ferritin at day 90 was 179 (38) ng/mL and 157 (34) ng/mL with iron(III) polymaltose complex and ferrous sulfate, respectively (p = 0.014). Adverse events were significantly less frequent in the iron(III) polymaltose group, occurring in 12/41 (29.3%) patients, than in the ferrous sulfate group (22/39 [56.4%]) (p = 0.015). CONCLUSIONS Oral iron(III) polymaltose complex offers at least equivalent efficacy and a superior safety profile compared to ferrous sulfate for the treatment of iron-deficiency anemia during pregnancy.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011250 Pregnancy Complications, Hematologic The co-occurrence of pregnancy and a blood disease (HEMATOLOGIC DISEASES) which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS. Complications, Hematologic Pregnancy,Hematologic Pregnancy Complications,Pregnancy Complications, Hematological,Pregnancy, Hematologic Complications,Complication, Hematologic Pregnancy,Complication, Hematological Pregnancy,Complications, Hematological Pregnancy,Hematologic Pregnancy Complication,Hematological Pregnancy Complication,Hematological Pregnancy Complications,Pregnancies, Hematologic Complications,Pregnancy Complication, Hematologic,Pregnancy Complication, Hematological
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D004909 Erythrocyte Indices ERYTHROCYTE size and HEMOGLOBIN content or concentration, usually derived from ERYTHROCYTE COUNT; BLOOD hemoglobin concentration; and HEMATOCRIT. The indices include the mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), and the mean corpuscular hemoglobin concentration (MCHC). Erythrocyte Hemoglobin, Mean Cell,Erythrocyte Size Determination,Erythrocyte Volume, Mean Cell,Hemoglobin, Erythrocyte, Mean Cell,Mean Corpuscular Volume,Red Cell Indices,Erythrocyte Diameter,Erythrocyte Index,Erythrocyte Indexes,Erythrocyte Thickness,Mean Cell Hemoglobin Concentration,Mean Cell Volume,Mean Corpuscular Hemoglobin,Mean Corpuscular Hemoglobulin Concentration,Red Cell Distribution Width,Red Cell Index,Red Cell Indexes,Cell Volumes, Mean,Corpuscular Volumes, Mean,Determination, Erythrocyte Size,Determinations, Erythrocyte Size,Diameter, Erythrocyte,Diameters, Erythrocyte,Erythrocyte Diameters,Erythrocyte Size Determinations,Hemoglobin, Mean Corpuscular,Hemoglobins, Mean Corpuscular,Index, Erythrocyte,Index, Red Cell,Indexes, Erythrocyte,Indexes, Red Cell,Indices, Erythrocyte,Indices, Red Cell,Mean Cell Volumes,Mean Corpuscular Hemoglobins,Mean Corpuscular Volumes,Size Determination, Erythrocyte,Size Determinations, Erythrocyte,Thickness, Erythrocyte,Volume, Mean Cell,Volume, Mean Corpuscular,Volumes, Mean Cell,Volumes, Mean Corpuscular
D005260 Female Females
D005290 Ferric Compounds Inorganic or organic compounds containing trivalent iron. Compounds, Ferric
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D005296 Ferrous Compounds Inorganic or organic compounds that contain divalent iron. Compounds, Ferrous
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages

Related Publications

Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children.
October 2009, Indian pediatrics,
Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia.
January 2011, International journal of pediatrics,
Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Comparison of efficacy & safety of iron polymaltose complex & ferrous ascorbate with ferrous sulphate in pregnant women with iron-deficiency anaemia.
July 2021, The Indian journal of medical research,
Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women.
June 2010, Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine,
Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia.
October 2019, Minerva pediatrica,
Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study.
January 2009, Acta obstetricia et gynecologica Scandinavica,
Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Comparison of Therapeutic Efficacy of Ferrous Ascorbate and Iron Polymaltose Complex in Iron Deficiency Anemia in Children: A Randomized Controlled Trial.
December 2019, Indian journal of pediatrics,
Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women.
January 2007, MedGenMed : Medscape general medicine,
Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
[Efficacy of complex Hongyibuxue oral solution and ferrous sulfate for iron deficiency anemia].
June 2005, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Ricardo Ortiz, and Jorge Eduardo Toblli, and Juan Diego Romero, and Beatriz Monterrosa, and Cristina Frer, and Eugenia Macagno, and Christian Breymann
Effect of oral tetracycline on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study.
January 2007, Arzneimittel-Forschung,
Copied contents to your clipboard!